Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-019815
Filing Date
2020-07-21
Accepted
2020-07-21 17:34:33
Documents
1
Period of Report
2020-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10402
  Complete submission text file 0000899243-20-019815.txt   12405
Mailing Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036
Business Address
SHAW DAVID E (Reporting) CIK: 0001023870 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39385 | Film No.: 201039642

Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Issuer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1166 AVENUE OF THE AMERICAS, NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS, NINTH FLOOR NEW YORK NY 10036 212-478-0000
Picularium, LLC (Reporting) CIK: 0001817110 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39385 | Film No.: 201039641